4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001628280-25-013145
Chief Commercial Officer gave up 9,576 shares (to pay taxes)
- Chief Commercial Officer acquired 99,227 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Verratti Mark Chief Commercial Officer | 2025-03-13 | Grant or award | +99,227 | 401,262 | D | ||
| Verratti Mark Chief Commercial Officer | 2025-03-14 | Shares withheld for taxes | −5,847 | $10.07 | $58,879 | 395,415 | D |
| Verratti Mark Chief Commercial Officer | 2025-03-15 | Shares withheld for taxes | −3,729 | $10.07 | $37,551 | 391,686 | D |
Loading xslF345X05/wk-form4_1742242769.xml…